(Q42721099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

editorial

0 references

title

Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

M I Restrepo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Anzueto

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

European Respiratory Journal

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Severity prediction rules in community acquired pneumonia: a validation study

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

A prediction rule to identify low-risk patients with community-acquired pneumonia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4082328

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia

16 August 2018

1 reference

12 December 2020

Acute exacerbation of chronic obstructive pulmonary disease: more a functional than an inflammatory problem?

1 reference

12 December 2020

Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia

1 reference

12 December 2020

Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia

1 reference

12 December 2020

10.1183/09031936.00028711

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21719494%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference